{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T01:41:36Z","timestamp":1790214096968,"version":"4.1.0"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T00:00:00Z","timestamp":1738195200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology Reports"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.toxrep.2025.101940","type":"journal-article","created":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T16:21:40Z","timestamp":1738426900000},"page":"101940","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Rising incidence of recreational ketamine use: Clinical cases and management in emergency settings"],"prefix":"10.1016","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-7355-5721","authenticated-orcid":false,"given":"Sabrina","family":"Marongiu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maarten","family":"van Eijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Femke M.J.","family":"Gresnigt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther A.","family":"Croes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric J.F.","family":"Franssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.toxrep.2025.101940_bib1","unstructured":"European Union Drugs Agency (EUDA), European Drug Report 2024: European Monitoring Centre for Drugs and Drug Addiction; 2024 [Nov 15, 2024]. Available from: \u3008https:\/\/www.euda.europa.eu\/\u3009."},{"key":"10.1016\/j.toxrep.2025.101940_bib2","unstructured":"Nationale Drug Monitor: Kerncijfertabel Gezondheidsenqu\u00eate en Leefstijlmonitor 2015-2023: Trimbos-instituut, Utrecht & WODC, Den Haag; 2024 [Nov 15, 2024]. Available from: \u3008https:\/\/www.nationaledrugmonitor.nl\/kerncijfertabel-gezondheidsenquette\/\u3009."},{"key":"10.1016\/j.toxrep.2025.101940_bib3","series-title":"Het Grote Uitgaansonderzoek 2023: Uitgaanspatronen, middelengebruik, gezondheid en intentie tot stoppen of minderen onder uitgaande jongeren en jongvolwassenen","author":"van Beek","year":"2023"},{"issue":"1","key":"10.1016\/j.toxrep.2025.101940_bib4","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/s12954-024-01071-1","article-title":"Reframing Dutch drug policies: a new era for harm reduction","volume":"21","author":"Busz","year":"2024","journal-title":"Harm Reduct. J."},{"key":"10.1016\/j.toxrep.2025.101940_bib5","volume":"2024","author":"Sch\u00fcrmann","year":"2022"},{"issue":"3","key":"10.1016\/j.toxrep.2025.101940_bib6","doi-asserted-by":"crossref","first-page":"38247","DOI":"10.52965\/001c.38247","article-title":"Ketamine-induced cystitis: a comprehensive review of the urologic effects of this psychoactive drug","volume":"10","author":"Anderson","year":"2022","journal-title":"Health Psychol. Res."},{"issue":"3","key":"10.1016\/j.toxrep.2025.101940_bib7","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1124\/pr.117.015198","article-title":"Ketamine and ketamine metabolite pharmacology: insights into therapeutic mechanisms","volume":"70","author":"Zanos","year":"2018","journal-title":"Pharm. Rev."},{"issue":"17","key":"10.1016\/j.toxrep.2025.101940_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10173978","article-title":"Efficacy and safety of intranasal ketamine for acute pain management in the emergency setting: a systematic review and meta-analysis","volume":"10","author":"Seak","year":"2021","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.toxrep.2025.101940_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyg.2021.648691","article-title":"Intranasal ketamine for depression in adults: a systematic review and meta-analysis of randomized, double-blind, placebo-controlled trials","volume":"12","author":"An","year":"2021","journal-title":"Front. Psychol."},{"issue":"1","key":"10.1016\/j.toxrep.2025.101940_bib10","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1515\/sjpain-2021-0079","article-title":"Ketamine therapy for chronic pain in The Netherlands: a nationwide survey","volume":"22","author":"Mangnus","year":"2022","journal-title":"Scand. J. Pain."},{"key":"10.1016\/j.toxrep.2025.101940_bib11","unstructured":"OPEN Foundation. Ketamine in de Nederlandse GGZ. [Dec 12, 2024]. Available from: \u3008https:\/\/open-foundation.org\/ketamine-nederlandse-ggz\/\u3009."},{"key":"10.1016\/j.toxrep.2025.101940_bib12","unstructured":"Ketamine en esketamine: Nationaal Vergiftigingen Informatie Centrum; 2024 [Nov 15, 2024]. Available from: \u3008https:\/\/www.vergiftigingen.info\/f?p=\u202f300:1210:967189442515:::RP,1210,1040\u3009."},{"key":"10.1016\/j.toxrep.2025.101940_bib13","unstructured":"Monografie ketamine 2024 [Nov 15, 2024]. Version 5 [Available from: \u3008https:\/\/toxicologie.org\/ketamine\/\u3009."},{"issue":"2","key":"10.1016\/j.toxrep.2025.101940_bib14","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1080\/00952990.2022.2132506","article-title":"Overdoses and deaths related to the use of ketamine and its analogues: a systematic review","volume":"49","author":"Chaves","year":"2023","journal-title":"Am. J. Drug Alcohol Abus."},{"issue":"3","key":"10.1016\/j.toxrep.2025.101940_bib15","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1080\/02791072.2004.10400031","article-title":"Acute toxic effects of club drugs","volume":"36","author":"Gable","year":"2004","journal-title":"J. Psychoact. Drugs"},{"key":"10.1016\/j.toxrep.2025.101940_bib16","doi-asserted-by":"crossref","DOI":"10.3389\/fnana.2022.795231","article-title":"Brain changes associated with long-term ketamine abuse, a systematic review","volume":"16","author":"Strous","year":"2022","journal-title":"Front. Neuroanat."},{"issue":"5","key":"10.1016\/j.toxrep.2025.101940_bib17","first-page":"521","article-title":"Consensus guidelines on the use of intravenous ketamine infusions for chronic pain from the American society of regional anesthesia and pain medicine, the American academy of pain medicine, and the American society of anesthesiologists","volume":"43","author":"Cohen","year":"2018","journal-title":"Reg. Anesth. Pain. Med."},{"issue":"4","key":"10.1016\/j.toxrep.2025.101940_bib18","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1002\/nau.24341","article-title":"What urologists need to know about ketamine-induced uropathy: a systematic review","volume":"39","author":"Castellani","year":"2020","journal-title":"Neurourol. Urodyn."},{"issue":"1","key":"10.1016\/j.toxrep.2025.101940_bib19","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1046\/j.1464-410X.2003.04018.x","article-title":"The agony and the ecstasy\u2019: acute urinary retention after MDMA abuse","volume":"91","author":"Inman","year":"2003","journal-title":"BJU Int."},{"issue":"3","key":"10.1016\/j.toxrep.2025.101940_bib20","doi-asserted-by":"crossref","first-page":"205","DOI":"10.4103\/tcmj.tcmj_94_23","article-title":"Pathophysiology, clinical presentation, and management of ketamine-induced cystitis","volume":"35","author":"Jhang","year":"2023","journal-title":"Tzu Chi Med. J."},{"issue":"1","key":"10.1016\/j.toxrep.2025.101940_bib21","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12888-023-05468-3","article-title":"Ketamine cystitis following ketamine therapy for treatment-resistant depression \u2013 case report","volume":"24","author":"Chang","year":"2024","journal-title":"BMC Psychiatry"},{"issue":"2","key":"10.1016\/j.toxrep.2025.101940_bib22","first-page":"44","article-title":"Themapoli voor ketamine-ge\u00efnduceerde cystitis: eerste ervaringen en resultaten","volume":"13","author":"van der Sanden","year":"2023","journal-title":"Tijdschr. voor Urol."},{"key":"10.1016\/j.toxrep.2025.101940_bib23","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.toxrep.2020.04.007","article-title":"Toxicological screening in the Amsterdam acute setting becomes more relevant if the standard panel of the drugs-of-abuse point-of-care test is expanded with GHB and ketamine","volume":"7","author":"van der Schaar","year":"2020","journal-title":"Toxicol. Rep."},{"issue":"11","key":"10.1016\/j.toxrep.2025.101940_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/metabo14110643","article-title":"Rapid determination of methamphetamine, methylenedioxymethamphetamine, methadone, ketamine, cocaine, and new psychoactive substances in urine samples using comprehensive two-dimensional gas chromatography","volume":"14","author":"Chandra Siri","year":"2024","journal-title":"Metabolites"},{"key":"10.1016\/j.toxrep.2025.101940_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2024.115975","article-title":"Method development for the quantification of nine nitazene analogs and brorphine in dried blood spots utilizing liquid chromatography \u2013 tandem mass spectrometry","volume":"241","author":"Ververi","year":"2024","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.toxrep.2025.101940_bib26","article-title":"Ketamine use in a large global sample: characteristics, patterns of use and emergency medical treatment","author":"Barrios","year":"2024","journal-title":"J. Psychopharmacol."}],"container-title":["Toxicology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214750025000587?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214750025000587?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T00:43:48Z","timestamp":1750207428000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214750025000587"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":26,"alternative-id":["S2214750025000587"],"URL":"https:\/\/doi.org\/10.1016\/j.toxrep.2025.101940","relation":{},"ISSN":["2214-7500"],"issn-type":[{"value":"2214-7500","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rising incidence of recreational ketamine use: Clinical cases and management in emergency settings","name":"articletitle","label":"Article Title"},{"value":"Toxicology Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.toxrep.2025.101940","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"101940"}}